(S (NP-SBJ (NN Leukotriene) (NN B4)) (VP (VBZ stimulates) (NP (NP-COOD (NP (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (NN gene) (NN transcription)) (CC and) (NP (NN AP-1) (NN binding) (NN activity))) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (NN leukotriene) (NN B4)) (PRN (-LRB- -LRB-) (NP (NN LTB4)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ potent) (NN lipid) (JJ proinflammatory) (NN mediator)) (, ,))) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NNS proto-oncogenes) (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos)))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (PRP we)) (VP (VBD looked) (PP (IN at) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (NP (JJ nuclear) (NNS factors)) (VP (VBG binding) (PP (RB specifically) (TO to) (NP (DT the) (NN AP-1) (NN element))) (PP-TMP (IN after) (NP (NN LTB4) (NN stimulation))))))))) (. .))
(S (NP-SBJ (NN LTB4)) (VP (VBD increased) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NN c-fos) (NN gene)))) (PP (IN in) (NP (DT a) (ADJP-COOD (ADJP (NP (NN time-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ concentration-dependent))) (NN manner)))) (. .))
(S (NP-SBJ-59 (NP (DT The) (NN c-jun) (NN mRNA)) (, ,) (SBAR (WHNP-60 (WDT which)) (S (NP-SBJ-61 (-NONE- *T*-60)) (VP (VBZ is) (ADVP (RB constitutively)) (VP (VBN expressed) (NP (-NONE- *-61)) (PP (IN in) (NP (JJ human) (NN peripheral-blood) (NNS monocytes))) (PP (IN at) (NP (ADJP (RB relatively) (JJ high)) (NNS levels))))))) (, ,)) (VP (VBD was) (ADVP (RB also)) (ADVP (RB slightly)) (VP (JJ augmented) (NP (-NONE- *-59)) (PP (IN by) (NP-LGS (NN LTB4))) (, ,) (SBAR-ADV (IN although) (FRAG (PP (TO to) (NP (NP (DT a) (ADJP (RB much) (JJR lower)) (NN extent)) (PP (IN than) (NP (NN c-fos))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NNS kinetics)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (CD two) (NNS genes)))))) (VP (VBD were) (ADJP-PRD (RB also) (RB slightly) (JJ different)) (, ,) (PP (IN with) (S-COOD (S (NP-SBJ-62 (NN c-fos) (NN mRNA)) (VP (VBG reaching) (NP (DT a) (NN peak)) (PP-TMP-63 (IN at) (NP (NP (CD 15) (NN min)) (PP-TMP (IN after) (NP (NN stimulation))))))) (CC and) (S (NP-SBJ=62 (NN c-jun)) (PP-TMP=63 (IN at) (NP (CD 30) (NN min))))))) (. .))
(S (NP-SBJ (DT Both) (NNS messages)) (ADVP-TMP (RB rapidly)) (VP (VBD declined) (ADVP (RB thereafter))) (. .))
(S (NP-SBJ-64 (NP (NN Stability)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (NN mRNA)))) (VP (VBD was) (RB not) (VP (VBN affected) (NP-103 (-NONE- *-64)) (PP (IN by) (NP-LGS (NN LTB4))) (, ,) (SBAR (IN as) (S (NP-SBJ-65 (-NONE- *-103)) (VP (VBN assessed) (NP (-NONE- *-65)) (PP-TMP (IN after) (NP (NN actinomycin) (NN D) (NN treatment)))))))) (. .))
(S (NP-SBJ (NP (JJ Nuclear) (NN transcription) (NNS studies)) (ADVP (FW in) (FW vitro))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NN LTB4)) (VP-COOD (VP (VBD increased) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP-66 (DT the) (NN c-fos) (NN gene)))) (ADVP-67 (RB 7-fold))) (CC and) (VP (NP=66 (DT the) (NN c-jun) (NN gene)) (ADVP=67 (RB 1.4-fold))))))) (. .))
(S-COOD (S (NP-SBJ (VBG Resting) (NNS monocytes)) (VP (VBD contained) (NP (NP (JJ nuclear) (NNS factors)) (VP (VBG binding) (PP (TO to) (NP (DT the) (NN AP-1) (NN element))))))) (, ,) (CC but) (S (NP-SBJ (NP (NN stimulation)) (PP (IN of) (NP (NNS monocytes))) (PP (IN with) (NP (NN LTB4)))) (VP (VBD induced) (NP (NP (JJR greater) (JJ AP-1-binding) (NN activity)) (PP (IN of) (NP (JJ nuclear) (NNS proteins)))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-68 (NN LTB4)) (VP (MD may) (VP (VB regulate) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (JJ different) (NNS cytokines)))) (PP (IN by) (S (NP-SBJ (-NONE- *-68)) (VP (VBG modulating) (NP (NP-COOD (NP (DT the) (NN yield)) (CC (or and)) (NP (DT the) (NN function))) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (PP (JJ such) (IN as) (NP (JJ AP-1-binding) (NN proto-oncogene) (NNS products)))))))))))))) (. .))
